Review of Transporter Substrate, Inhibitor, and Inducer Characteristics of Cladribine.


Journal

Clinical pharmacokinetics
ISSN: 1179-1926
Titre abrégé: Clin Pharmacokinet
Pays: Switzerland
ID NLM: 7606849

Informations de publication

Date de publication:
12 2021
Historique:
accepted: 28 07 2021
pubmed: 27 8 2021
medline: 28 1 2022
entrez: 26 8 2021
Statut: ppublish

Résumé

Cladribine is a nucleoside analog that is phosphorylated in its target cells (B- and T-lymphocytes) to its active adenosine triphosphate form (2-chlorodeoxyadenosine triphosphate). Cladribine tablets 10 mg (Mavenclad

Identifiants

pubmed: 34435310
doi: 10.1007/s40262-021-01065-3
pii: 10.1007/s40262-021-01065-3
pmc: PMC8613159
doi:

Substances chimiques

ATP Binding Cassette Transporter, Subfamily G, Member 2 0
ATP-Binding Cassette Transporters 0
Membrane Transport Proteins 0
Neoplasm Proteins 0
Cladribine 47M74X9YT5

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1509-1535

Subventions

Organisme : merck healthcare kgaa
ID : CrossRef Funder ID: 10.13039/100009945

Informations de copyright

© 2021. The Author(s).

Références

Am J Physiol. 1999 Jan;276(1):F122-8
pubmed: 9887087
AAPS J. 2011 Dec;13(4):519-47
pubmed: 21818695
Xenobiotica. 2006 Oct-Nov;36(10-11):963-88
pubmed: 17118916
Curr Opin Neurol. 2018 Jun;31(3):233-243
pubmed: 29634596
Clin Pharmacol Ther. 2013 Jul;94(1):3-9
pubmed: 23778703
Pharmacogenomics J. 2005;5(3):157-65
pubmed: 15738947
Pharmacol Ther. 2012 Oct;136(1):106-30
pubmed: 22841915
Clin Pharmacol Ther. 2019 Nov;106(5):1083-1092
pubmed: 31127606
Biochem Pharmacol. 2013 Sep 15;86(6):808-15
pubmed: 23876341
Mult Scler Relat Disord. 2016 Sep;9 Suppl 1:S5-S48
pubmed: 27640924
Expert Opin Drug Metab Toxicol. 2010 May;6(5):571-89
pubmed: 20367109
Pflugers Arch. 2004 Feb;447(5):735-43
pubmed: 12838422
Physiol Rev. 2015 Jan;95(1):83-123
pubmed: 25540139
Leukemia. 2004 Mar;18(3):385-93
pubmed: 14737075
Drug Metab Dispos. 2003 May;31(5):523-7
pubmed: 12695338
Mol Cancer Ther. 2008 Sep;7(9):3092-102
pubmed: 18765824
Nat Rev Drug Discov. 2010 Mar;9(3):215-36
pubmed: 20190787
Mol Pharmacol. 2001 May;59(5):1277-86
pubmed: 11306713
Neurol Neuroimmunol Neuroinflamm. 2017 Jun 05;4(4):e360
pubmed: 28626781
Mol Pharmacol. 2004 Apr;65(4):925-33
pubmed: 15044622
Drug Metab Pharmacokinet. 2005 Dec;20(6):452-77
pubmed: 16415531
J Biol Chem. 2001 Sep 7;276(36):33747-54
pubmed: 11447229
Cancer Res. 2007 Jul 15;67(14):6965-72
pubmed: 17638908
Clin Pharmacokinet. 2019 Mar;58(3):283-297
pubmed: 29987837
Am J Physiol Endocrinol Metab. 2003 Feb;284(2):E390-8
pubmed: 12409283
Biochem Pharmacol. 2012 Apr 15;83(8):1073-83
pubmed: 22285911
Xenobiotica. 2008 Jul;38(7-8):778-801
pubmed: 18668430
Xenobiotica. 2007 Aug;37(8):818-31
pubmed: 17701831
AAPS J. 2015 Jul;17(4):802-12
pubmed: 25840885
Mol Pharm. 2016 Mar 7;13(3):933-44
pubmed: 26871298
Nucleosides Nucleotides Nucleic Acids. 2011 Dec;30(12):1324-40
pubmed: 22132993
Drug Metab Dispos. 2019 Aug;47(8):802-808
pubmed: 31123036
Lancet. 2008 Oct 25;372(9648):1502-17
pubmed: 18970977
Lancet. 1992 Oct 17;340(8825):952-6
pubmed: 1357355
Physiol Rev. 2006 Jul;86(3):849-99
pubmed: 16816140
Pflugers Arch. 2012 Dec;464(6):601-11
pubmed: 23014881
Biochem Pharmacol. 2007 Jan 1;73(1):147-54
pubmed: 17046718
Sci Rep. 2019 Sep 19;9(1):13555
pubmed: 31537831
Eur J Pharmacol. 2012 Sep 5;690(1-3):183-91
pubmed: 22709993
Mol Pharmacol. 2021 Feb;99(2):147-162
pubmed: 33262250
Expert Opin Pharmacother. 2013 Jan;14(1):123-36
pubmed: 23256518
J Neurol. 2018 May;265(5):1199-1209
pubmed: 29550884
J Biol Chem. 2001 Jan 26;276(4):2914-27
pubmed: 11032837
PLoS One. 2008 Jun 04;3(6):e2353
pubmed: 18523561
Clin Pharmacol Ther. 2019 Jul;106(1):228-237
pubmed: 30673124
J Proteome Res. 2015 Aug 7;14(8):3305-14
pubmed: 26167961
Am J Physiol Renal Physiol. 2007 Feb;292(2):F682-90
pubmed: 17018840
Toxicology. 2013 Sep 15;311(3):135-46
pubmed: 23856525
Front Pharmacol. 2015 Apr 10;6:78
pubmed: 25914645
J Pharm Pharmacol. 2005 May;57(5):573-8
pubmed: 15901346
Pharmacol Res. 2016 Sep;111:237-246
pubmed: 27317943
J Am Soc Nephrol. 2002 Apr;13(4):866-874
pubmed: 11912245
J Biol Chem. 2004 Nov 26;279(48):50042-9
pubmed: 15448143
FASEB J. 2019 Mar;33(3):3841-3850
pubmed: 30521377
Neuroscience. 2004;129(2):349-60
pubmed: 15501592
Am J Physiol Renal Physiol. 2007 Jul;293(1):F200-11
pubmed: 17409283
N Engl J Med. 2010 Feb 4;362(5):416-26
pubmed: 20089960
J Pharmacol Exp Ther. 2002 Mar;300(3):918-24
pubmed: 11861798
J Manag Care Pharm. 2013 Jan-Feb;19(1 Suppl A):S24-40
pubmed: 23383731
J Pharmacol Exp Ther. 2002 Jun;301(3):797-802
pubmed: 12023506
Leukemia. 2000 Jan;14(1):52-60
pubmed: 10637477
Biochim Biophys Acta. 2002 Jun 12;1590(1-3):64-75
pubmed: 12063169
Eur J Pharmacol. 2003 Oct 31;479(1-3):269-81
pubmed: 14612157
Circ Res. 2006 Sep 1;99(5):510-9
pubmed: 16873718
Pharm Res. 2016 Sep;33(9):2280-8
pubmed: 27356525
Biochem Pharmacol. 2005 Sep 15;70(6):949-58
pubmed: 16054595
Arch Toxicol. 2016 Jul;90(7):1555-84
pubmed: 27165417
J Pharm Sci. 2019 Jul;108(7):2476-2483
pubmed: 30794795
J Neurochem. 2011 Apr;117(2):333-45
pubmed: 21291474
Xenobiotica. 2017 Jan;47(1):77-85
pubmed: 27052107
Br J Pharmacol. 2011 Jun;163(3):546-55
pubmed: 20883471
J Pharmacol Exp Ther. 2008 Feb;324(2):558-67
pubmed: 18042828
Int J Mol Sci. 2019 Oct 24;20(21):
pubmed: 31653114
Mol Pharmacol. 2006 Jan;69(1):346-53
pubmed: 16234483
Int J Biochem Mol Biol. 2016 Jun 01;7(1):11-8
pubmed: 27335682
Med Res Rev. 2012 Mar;32(2):428-57
pubmed: 21287570
Reprod Toxicol. 2015 Nov;57:176-82
pubmed: 26169552
Clin Pharmacol Ther. 2019 May;105(5):1204-1212
pubmed: 30447067
Mult Scler Relat Disord. 2019 Apr;29:168-174
pubmed: 30885375
J Pharmacol Sci. 2004 Mar;94(3):297-304
pubmed: 15037815
Eur J Med Chem. 2015 Mar 6;92:723-31
pubmed: 25618019
Am J Physiol Gastrointest Liver Physiol. 2008 Sep;295(3):G570-80
pubmed: 18635603
Cancer Lett. 2008 Feb 18;260(1-2):163-9
pubmed: 18082941
Clin Pharmacol Ther. 2013 Jul;94(1):52-63
pubmed: 23588305
Curr Pharm Des. 2014;20(5):793-807
pubmed: 23688078
Clin Pharmacokinet. 2017 Oct;56(10):1245-1253
pubmed: 28255849
J Pharmacol Exp Ther. 1999 Jun;289(3):1487-91
pubmed: 10336543
Drugs. 2017 May;77(8):859-883
pubmed: 28382570
Drug Metab Dispos. 2012 Mar;40(3):617-24
pubmed: 22190696
Toxicol Appl Pharmacol. 2008 Dec 15;233(3):428-38
pubmed: 18930752
Br J Pharmacol. 2012 Mar;165(5):1260-87
pubmed: 22013971
Mol Pharm. 2011 Aug 1;8(4):1332-41
pubmed: 21707071
Kidney Int. 2008 Jan;73(2):220-5
pubmed: 17978814
Bull Exp Biol Med. 2016 Apr;160(6):771-4
pubmed: 27160886
Clin Pharmacol Ther. 2016 Jun;99(6):651-60
pubmed: 26663398
Nat Rev Drug Discov. 2015 Jan;14(1):29-44
pubmed: 25475361
Pharm Res. 2007 Jul;24(7):1227-51
pubmed: 17473959
Pharmacol Res. 2015 Jan;91:78-87
pubmed: 25481222
Ther Adv Neurol Disord. 2019 Jun 18;12:1756286419854986
pubmed: 31244898
Nucleosides Nucleotides Nucleic Acids. 2017 Jan 2;36(1):7-30
pubmed: 27759477
Infection. 2013 Apr;41(2):379-85
pubmed: 22875535
Pharm Res. 2009 Sep;26(9):2039-54
pubmed: 19568696
Blood. 1992 Dec 1;80(11):2735-9
pubmed: 1360267
J Biol Chem. 2006 Sep 8;281(36):26675-82
pubmed: 16840788
Eur J Haematol. 2003 Aug;71(2):119-23
pubmed: 12890151
Drug Metab Dispos. 2017 Mar;45(3):269-278
pubmed: 28062543
Clin Pharmacokinet. 1997 Feb;32(2):120-31
pubmed: 9068927
Clin Pharmacol Ther. 2013 Jul;94(1):80-94
pubmed: 23588303
Pflugers Arch. 2004 Feb;447(5):728-34
pubmed: 12856181
Eur J Pharmacol. 2004 Jan 12;483(2-3):133-8
pubmed: 14729100
J Physiol. 2004 Aug 1;558(Pt 3):807-23
pubmed: 15194733
Arch Toxicol. 2014 Jun;88(6):1205-48
pubmed: 24777822
Drug Metab Dispos. 2013 Apr;41(4):683-8
pubmed: 23340958
Neurochem Int. 2014 Jul;73:229-37
pubmed: 24704797
Biochem Soc Trans. 2016 Jun 15;44(3):869-76
pubmed: 27284054
Mol Pharmacol. 2003 May;63(5):1094-103
pubmed: 12695538
Mol Aspects Med. 2013 Apr-Jun;34(2-3):529-47
pubmed: 23506887

Auteurs

Robert Hermann (R)

Clinical Research Appliance (cr.appliance), Heinrich-Vingerhut-Weg 3, 63571, Gelnhausen, Germany. robert.hermann@cr-appliance.com.

Peter Krajcsi (P)

Habilitas Kft, Budapest, Hungary.

Markus Fluck (M)

Merck Healthcare KGaA, Darmstadt, Germany.

Annick Seithel-Keuth (A)

Merck Healthcare KGaA, Darmstadt, Germany.

Afrim Bytyqi (A)

Merck Healthcare KGaA, Darmstadt, Germany.

Andrew Galazka (A)

Merck Healthcare KGaA, Darmstadt, Germany.

Alain Munafo (A)

Institute of Pharmacometrics, an Affiliate of Merck KGaA, Lausanne, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH